This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
BBS-Bioactive Bone Substitutes Oyj Toekomstige groei
Future criteriumcontroles 2/6
BBS-Bioactive Bone Substitutes Oyj's earnings are forecast to decline at 10.3% per annum while its annual revenue is expected to grow at 78.8% per year. EPS is expected to grow by 4.5% per annum.
Belangrijke informatie
-10.3%
Groei van de winst
4.5%
Groei van de winst per aandeel
| Biotechs winstgroei | 35.0% |
| Inkomstengroei | 78.8% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 21 Nov 2023 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -4 | -5 | -4 | 1 |
| 12/31/2024 | 0 | -5 | -4 | -4 | 1 |
| 12/31/2023 | N/A | -4 | 1 | -3 | 1 |
| 3/31/2023 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2020 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 6/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2020 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2019 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2019 | N/A | -1 | -2 | -2 | N/A |
| 12/31/2018 | N/A | 0 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -1 | -2 | -2 | N/A |
| 6/30/2018 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -4 | -2 | -1 | N/A |
| 12/31/2017 | N/A | -4 | -1 | -1 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -1 | N/A | 0 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: BONEHU0223's revenue (78.8% per year) is forecast to grow faster than the Finnish market (2.7% per year).
Hoge groei-inkomsten: BONEHU0223's revenue (78.8% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if BONEHU0223's Return on Equity is forecast to be high in 3 years time